Schwannomatosis associated with multiple meningiomas due to a familial SMARCB1 mutation
- PMID: 19582488
- DOI: 10.1007/s10048-009-0204-2
Schwannomatosis associated with multiple meningiomas due to a familial SMARCB1 mutation
Abstract
Schwannomatosis (MIM 162091) is a condition predisposing to the development of central and peripheral schwannomas; most cases are sporadic without a clear family history but a few families with a clear autosomal dominant pattern of transmission have been described. Germline mutations in SMARCB1 are associated with schwannomatosis. We report a family with multiple schwannomas and meningiomas. A SMARCB1 germline mutation in exon 1 was identified. The mutation, c.92A>T (p.Glu31Val), occurs in a highly conserved amino acid in the SMARCB1 protein. In addition, in silico analysis demonstrated that the mutation disrupts the donor consensus sequence of exon 1. RNA studies verified the absence of mRNA transcribed by the mutant allele. This is the first report of a SMARCB1 germline mutation in a family with schwannomatosis characterized by the development of multiple meningiomas.
Similar articles
-
Germline SMARCB1 mutation predisposes to multiple meningiomas and schwannomas with preferential location of cranial meningiomas at the falx cerebri.Neurogenetics. 2012 Feb;13(1):1-7. doi: 10.1007/s10048-011-0300-y. Epub 2011 Oct 26. Neurogenetics. 2012. PMID: 22038540
-
RNA-based analysis of two SMARCB1 mutations associated with familial schwannomatosis with meningiomas.Neurogenetics. 2012 Aug;13(3):267-74. doi: 10.1007/s10048-012-0335-8. Epub 2012 Jul 1. Neurogenetics. 2012. PMID: 22752724
-
Germline SMARCB1 mutation and somatic NF2 mutations in familial multiple meningiomas.J Med Genet. 2011 Feb;48(2):93-7. doi: 10.1136/jmg.2010.082420. Epub 2010 Oct 7. J Med Genet. 2011. PMID: 20930055
-
Cancer and Central Nervous System Tumor Surveillance in Pediatric Neurofibromatosis 2 and Related Disorders.Clin Cancer Res. 2017 Jun 15;23(12):e54-e61. doi: 10.1158/1078-0432.CCR-17-0590. Clin Cancer Res. 2017. PMID: 28620005 Review.
-
Germline and somatic mutations in meningiomas.Cancer Genet. 2015 Apr;208(4):107-14. doi: 10.1016/j.cancergen.2015.02.003. Epub 2015 Feb 19. Cancer Genet. 2015. PMID: 25857641 Review.
Cited by
-
Clinical features of schwannomatosis: a retrospective analysis of 87 patients.Oncologist. 2012;17(10):1317-22. doi: 10.1634/theoncologist.2012-0162. Epub 2012 Aug 27. Oncologist. 2012. PMID: 22927469 Free PMC article.
-
Somatic SMARCB1 Mutation in Sporadic Multiple Meningiomas: Case Report.Front Neurol. 2018 Oct 26;9:919. doi: 10.3389/fneur.2018.00919. eCollection 2018. Front Neurol. 2018. PMID: 30416484 Free PMC article.
-
Loss of SMARCE1 expression is a specific diagnostic marker of clear cell meningioma: a comprehensive immunophenotypical and molecular analysis.Brain Pathol. 2018 Jul;28(4):466-474. doi: 10.1111/bpa.12524. Epub 2017 Jun 12. Brain Pathol. 2018. PMID: 28474749 Free PMC article.
-
Segmental schwannomatosis: characteristics in 12 patients.Orphanet J Rare Dis. 2019 Aug 22;14(1):207. doi: 10.1186/s13023-019-1176-4. Orphanet J Rare Dis. 2019. PMID: 31438995 Free PMC article.
-
Genetic predisposition to peripheral nerve neoplasia: diagnostic criteria and pathogenesis of neurofibromatoses, Carney complex, and related syndromes.Acta Neuropathol. 2012 Mar;123(3):349-67. doi: 10.1007/s00401-011-0935-7. Epub 2011 Dec 31. Acta Neuropathol. 2012. PMID: 22210082 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources